Total Payments
$594,872
2024 Payments
$114,244
Companies
20
Transactions
561
Payment Breakdown by Category
Other$206,788 (34.8%)
Consulting$186,105 (31.3%)
Travel$170,138 (28.6%)
Food & Beverage$31,841 (5.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $198,548 | 96 | 33.4% |
| Consulting Fee | $186,105 | 86 | 31.3% |
| Travel and Lodging | $170,138 | 234 | 28.6% |
| Food and Beverage | $31,841 | 138 | 5.4% |
| Honoraria | $7,085 | 6 | 1.2% |
| Compensation for serving as faculty or as a speaker for an accredited or certified continuing education program | $1,155 | 1 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ascendis Pharma Inc | $158,133 | 226 | $0 (2024) |
| Novo Nordisk Health Care AG | $155,560 | 82 | $0 (2024) |
| BioMarin Pharmaceutical Inc. | $112,014 | 125 | $0 (2024) |
| Hexal AG | $56,970 | 33 | $0 (2018) |
| Novo Nordisk Inc | $32,208 | 37 | $0 (2023) |
| TOLMAR Pharmaceuticals, Inc. | $23,353 | 11 | $0 (2022) |
| Ipsen Biopharmaceuticals, Inc | $15,160 | 8 | $0 (2022) |
| Novo Nordisk AS | $12,250 | 4 | $0 (2018) |
| Endo Pharmaceuticals Inc. | $6,039 | 10 | $0 (2019) |
| Tolmar, Inc. | $5,895 | 6 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $114,244 | 91 | BioMarin Pharmaceutical Inc. ($54,677) |
| 2023 | $128,374 | 149 | Ascendis Pharma Inc ($47,642) |
| 2022 | $151,087 | 181 | Ascendis Pharma, Inc. ($71,774) |
| 2021 | $24,567 | 17 | Ipsen Biopharmaceuticals, Inc ($10,190) |
| 2020 | $6,803 | 7 | AbbVie Inc. ($1,688) |
| 2019 | $26,861 | 27 | Novo Nordisk Health Care AG ($15,497) |
| 2018 | $71,982 | 54 | Hexal AG ($27,311) |
| 2017 | $70,955 | 35 | Novo Nordisk Health Care AG ($31,688) |
All Payment Transactions
561 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/27/2024 | Ascendis Pharma Inc | Skytrofa (Drug) | Consulting Fee | Cash or cash equivalent | $2,572.00 | General |
| Category: Endocrinology | ||||||
| 12/10/2024 | BioMarin Pharmaceutical Inc. | VOXZOGO 1.2mg (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,750.00 | General |
| Category: Achondroplasia | ||||||
| 12/03/2024 | BioMarin Pharmaceutical Inc. | VOXZOGO 1.2mg (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,040.00 | General |
| Category: Achondroplasia | ||||||
| 11/21/2024 | BioMarin Pharmaceutical Inc. | VOXZOGO 1.2mg (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,425.00 | General |
| Category: Achondroplasia | ||||||
| 11/19/2024 | Novo Nordisk Health Care AG | — | Consulting Fee | Cash or cash equivalent | $8,156.25 | General |
| 11/19/2024 | Novo Nordisk Health Care AG | — | Travel and Lodging | In-kind items and services | $3,532.61 | General |
| 11/19/2024 | Novo Nordisk Health Care AG | — | Consulting Fee | Cash or cash equivalent | $3,375.00 | General |
| 11/19/2024 | Novo Nordisk Health Care AG | — | Travel and Lodging | In-kind items and services | $735.97 | General |
| 11/19/2024 | Novo Nordisk Health Care AG | — | Food and Beverage | In-kind items and services | $253.98 | General |
| 11/19/2024 | Novo Nordisk Health Care AG | — | Travel and Lodging | In-kind items and services | $96.17 | General |
| 11/16/2024 | BioMarin Pharmaceutical Inc. | VOXZOGO 1.2mg (Drug) | Food and Beverage | In-kind items and services | $74.15 | General |
| Category: Achondroplasia | ||||||
| 11/14/2024 | BioMarin Pharmaceutical Inc. | VOXZOGO 1.2mg (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,425.00 | General |
| Category: Achondroplasia | ||||||
| 11/14/2024 | BioMarin Pharmaceutical Inc. | VOXZOGO 1.2mg (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $855.00 | General |
| Category: Achondroplasia | ||||||
| 11/06/2024 | BioMarin Pharmaceutical Inc. | VOXZOGO 1.2mg (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,000.00 | General |
| Category: Achondroplasia | ||||||
| 10/31/2024 | BioMarin Pharmaceutical Inc. | VOXZOGO 1.2mg (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,425.00 | General |
| Category: Achondroplasia | ||||||
| 10/24/2024 | BioMarin Pharmaceutical Inc. | VOXZOGO 1.2mg (Drug) | Consulting Fee | Cash or cash equivalent | $2,000.00 | General |
| Category: Achondroplasia | ||||||
| 10/17/2024 | BioMarin Pharmaceutical Inc. | VOXZOGO 1.2mg (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,420.00 | General |
| Category: Achondroplasia | ||||||
| 10/15/2024 | BioMarin Pharmaceutical Inc. | VOXZOGO 1.2mg (Drug) | Travel and Lodging | In-kind items and services | $14,234.34 | General |
| Category: Achondroplasia | ||||||
| 10/15/2024 | BioMarin Pharmaceutical Inc. | VOXZOGO 1.2mg (Drug) | Travel and Lodging | In-kind items and services | $842.01 | General |
| Category: Achondroplasia | ||||||
| 10/15/2024 | BioMarin Pharmaceutical Inc. | VOXZOGO 1.2mg (Drug) | Food and Beverage | In-kind items and services | $272.49 | General |
| Category: Achondroplasia | ||||||
| 10/10/2024 | BioMarin Pharmaceutical Inc. | VOXZOGO 1.2mg (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,140.00 | General |
| Category: Achondroplasia | ||||||
| 10/03/2024 | BioMarin Pharmaceutical Inc. | VOXZOGO 1.2mg (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,420.00 | General |
| Category: Achondroplasia | ||||||
| 10/02/2024 | BioMarin Pharmaceutical Inc. | VOXZOGO 1.2mg (Drug) | Travel and Lodging | In-kind items and services | $1,389.50 | General |
| Category: Achondroplasia | ||||||
| 10/02/2024 | BioMarin Pharmaceutical Inc. | VOXZOGO 1.2mg (Drug) | Travel and Lodging | In-kind items and services | $792.81 | General |
| Category: Achondroplasia | ||||||
| 10/02/2024 | BioMarin Pharmaceutical Inc. | VOXZOGO 1.2mg (Drug) | Travel and Lodging | In-kind items and services | $288.29 | General |
| Category: Achondroplasia | ||||||
About Dr. Philippe Backeljauw, M.D
Dr. Philippe Backeljauw, M.D is a Pediatric Endocrinology healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2006. The National Provider Identifier (NPI) number assigned to this provider is 1770511883.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Philippe Backeljauw, M.D has received a total of $594,872 in payments from pharmaceutical and medical device companies, with $114,244 received in 2024. These payments were reported across 561 transactions from 20 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($198,548).
Ad
Practice Information
- Specialty Pediatric Endocrinology
- Location Cincinnati, OH
- Active Since 06/29/2006
- Last Updated 07/08/2007
- Taxonomy Code 2080P0205X
- Entity Type Individual
- NPI Number 1770511883
Products in Payments
- SKYTROFA (Drug) $119,416
- Norditropin (Drug) $88,466
- VOXZOGO 1.2mg (Drug) $61,136
- Omnitrope (Drug) $56,970
- Norditropin (Biological) $52,807
- Skytrofa (Drug) $38,549
- FENSOLVI (Drug) $29,248
- VOXZOGO 1.2mg (Biological) $18,158
- VOXZOGO (Biological) $11,195
- INCRELEX (Drug) $10,235
- Sogroya (Biological) $9,617
- SUPPRELIN (Drug) $5,967
- Increlex (Drug) $3,450
- OMNITROPE (Drug) $2,389
- LUPRON DEPOT (Drug) $1,688
- Thyquidity (Drug) $1,540
- Crysvita (Drug) $122.07
- Macrilen (Drug) $82.14
- SUPPRELIN LA (Drug) $71.48
- FREESTYLE LIBRE 3 (Device) $13.88
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pediatric Endocrinology Doctors in Cincinnati
Susan Rose, M.d, M.D
Pediatric Endocrinology — Payments: $17,064
Pediatric Endocrinology $17,064
Iris Gutmark-Little, M.d, M.D
Pediatric Endocrinology — Payments: $7,740
Pediatric Endocrinology $7,740
Halley Wasserman, M.d, M.D
Pediatric Endocrinology — Payments: $6,517
Pediatric Endocrinology $6,517
Amy Shah, M.d, M.D
Pediatric Endocrinology — Payments: $5,959
Pediatric Endocrinology $5,959
David Klein, M.d, M.D
Pediatric Endocrinology — Payments: $2,742
Pediatric Endocrinology $2,742
Deborah Elder, Md, MD
Pediatric Endocrinology — Payments: $2,100
Pediatric Endocrinology $2,100